Literature DB >> 1724707

Blood transcobalamin levels in malignant hepatoma.

S Frémont1, B Champigneulle, P Gérard, F Felden, D Lambert, J L Guéant, J P Nicolas.   

Abstract

Alpha-Fetoprotein (AFP) levels measured by RIA show a strong sensitivity for the biological diagnosis of malignant hepatoma (MH). However, this parameter lacks specificity. Previous observations of an alteration in vitamin B12 metabolism in the presence of hepatoma led us to study vitamin-B12-binding proteins. Vitamin B12, also called cobalamin, is transported in the blood by two proteins or transcobalamins: one is haptocorrin (HC), which is linked to most of the cobalamin, and the other is transcobalamin II, which is involved in tissue exchanges. In this work, the levels of AFP and transcobalamins were determined by RIA and radioisotope dilution assay, respectively. They were measured in patients with MH (group A) and in patients with other liver diseases (group B). Compared with group B, group A showed a significant increase in total serum HC (p less than 0.005). In conclusion, it was observed that MH is accompanied by increased levels of HC. The origin of these changes could be due to either an increase in HC synthesis or a catabolic defect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724707     DOI: 10.1159/000217736

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

1.  High vitamin B12 level and mortality in elderly inpatients.

Authors:  N Salles; F Herrmann; C Sieber; C Rapin
Journal:  J Nutr Health Aging       Date:  2008-03       Impact factor: 4.075

Review 2.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

3.  Falsely Elevated Serum Vitamin B12 Levels Were Associated with the Severity and Prognosis of Chronic Viral Liver Disease.

Authors:  Takaaki Sugihara; Masahiko Koda; Toshiaki Okamoto; Kenichi Miyoshi; Tomomitsu Matono; Kenji Oyama; Keiko Hosho; Jun-Ichi Okano; Hajime Isomoto; Yoshikazu Murawaki
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

4.  Plasma folate, vitamin B12, and homocysteine and cancers of the esophagus, stomach, and liver in a Chinese population.

Authors:  Shen-Chih Chang; Binh Y Goldstein; Lina Mu; Lin Cai; Nai-Chieh Y You; Na He; Bao-Guo Ding; Jin-Kou Zhao; Shun-Zhang Yu; David Heber; Zuo-Feng Zhang; Qing-Yi Lu
Journal:  Nutr Cancer       Date:  2015-01-21       Impact factor: 2.900

5.  Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels.

Authors:  Johan F B Arendt; Ebba Nexo
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

Review 6.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

7.  Hypercobalaminaemia is associated with hepatic and neoplastic disease in cats: a cross sectional study.

Authors:  Mary R Trehy; Alexander J German; Paolo Silvestrini; Goncalo Serrano; Daniel J Batchelor
Journal:  BMC Vet Res       Date:  2014-08-08       Impact factor: 2.741

Review 8.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09

9.  Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers.

Authors:  Ying Wang; Changli Yue; Jugao Fang; Lili Gong; Meng Lian; Ru Wang; Ling Feng; Hongzhi Ma; Zhihong Ma; Honggang Liu
Journal:  Onco Targets Ther       Date:  2018-07-24       Impact factor: 4.147

Review 10.  B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease.

Authors:  Peter Lyon; Victoria Strippoli; Byron Fang; Luisa Cimmino
Journal:  Nutrients       Date:  2020-09-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.